当前位置: 首页 >> 检索结果
共有 2156 条符合本次的查询结果, 用时 4.5521606 秒

1221. Osteoporosis prevention, diagnosis, and therapy.

作者: .
来源: JAMA. 2001年285卷6期785-95页
To clarify the factors associated with prevention, diagnosis, and treatment of osteoporosis, and to present the most recent information available in these areas.

1222. Interferon and ribavirin vs interferon alone in the re-treatment of chronic hepatitis C previously nonresponsive to interferon: A meta-analysis of randomized trials.

作者: K J Cummings.;S M Lee.;E S West.;J Cid-Ruzafa.;S G Fein.;Y Aoki.;M S Sulkowski.;S N Goodman.
来源: JAMA. 2001年285卷2期193-9页
Hepatitis C is the leading cause of chronic liver disease in the United States. Several trials have found that interferon and ribavirin combination therapy is more efficacious than interferon monotherapy for previously untreated patients and those who relapsed after prior interferon monotherapy, but its effectiveness for nonresponders to prior interferon monotherapy is unclear.

1223. MSJAMA: improving the practice of pain management.

作者: J L Dahl.
来源: JAMA. 2000年284卷21期2785页

1224. Coronary artery stents.

作者: J Al Suwaidi.;P B Berger.;D R Holmes.
来源: JAMA. 2000年284卷14期1828-36页
Intracoronary stents are now used for the majority of patients undergoing percutaneous coronary revascularization, and the body of scientific knowledge about stents has expanded rapidly in the last several years.

1225. Effect of patient reminder/recall interventions on immunization rates: A review.

作者: P G Szilagyi.;C Bordley.;J C Vann.;A Chelminski.;R M Kraus.;P A Margolis.;L E Rodewald.
来源: JAMA. 2000年284卷14期1820-7页
Immunization rates for children and adults remain below national goals. While experts recommend that health care professionals remind patients of needed immunizations, few practitioners actually use reminders. Little is known about the effectiveness of reminders in different settings or patient populations.

1226. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation.

作者: A T McLellan.;D C Lewis.;C P O'Brien.;H D Kleber.
来源: JAMA. 2000年284卷13期1689-95页
The effects of drug dependence on social systems has helped shape the generally held view that drug dependence is primarily a social problem, not a health problem. In turn, medical approaches to prevention and treatment are lacking. We examined evidence that drug (including alcohol) dependence is a chronic medical illness. A literature review compared the diagnoses, heritability, etiology (genetic and environmental factors), pathophysiology, and response to treatments (adherence and relapse) of drug dependence vs type 2 diabetes mellitus, hypertension, and asthma. Genetic heritability, personal choice, and environmental factors are comparably involved in the etiology and course of all of these disorders. Drug dependence produces significant and lasting changes in brain chemistry and function. Effective medications are available for treating nicotine, alcohol, and opiate dependence but not stimulant or marijuana dependence. Medication adherence and relapse rates are similar across these illnesses. Drug dependence generally has been treated as if it were an acute illness. Review results suggest that long-term care strategies of medication management and continued monitoring produce lasting benefits. Drug dependence should be insured, treated, and evaluated like other chronic illnesses. JAMA. 2000;284:1689-1695.

1227. Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.

作者: D L Bhatt.;E J Topol.
来源: JAMA. 2000年284卷12期1549-58页
The central role of platelet-rich thrombus in the pathogenesis of acute coronary syndromes (ACSs) is well-known. Glycoprotein IIb/IIIa (Gp IIb/IIIa) receptor antagonists are potent inhibitors of platelet function that may be expected to affect favorably the natural history of ACSs.

1228. Chorioamnionitis as a risk factor for cerebral palsy: A meta-analysis.

作者: Y W Wu.;J M Colford.
来源: JAMA. 2000年284卷11期1417-24页
Chorioamnionitis has been implicated in the pathogenesis of cerebral palsy, but most studies have not reported a significant association. Cystic periventricular leukomalacia (cPVL) is believed to be a precursor of cerebral palsy in preterm infants.

1229. Preoperative radiotherapy for resectable rectal cancer: A meta-analysis.

作者: C Cammà.;M Giunta.;F Fiorica.;L Pagliaro.;A Craxì.;M Cottone.
来源: JAMA. 2000年284卷8期1008-15页
The benefit of adjuvant radiotherapy for resectable rectal cancer has been extensively studied, but data on survival are still equivocal despite a reduction in the rate of local recurrence.

1230. Management changes in primary hyperparathyroidism.

作者: G L Irvin.;D M Carneiro.
来源: JAMA. 2000年284卷8期934-6页

1231. Characteristics and management of postpolio syndrome.

作者: B Jubelt.;J C Agre.
来源: JAMA. 2000年284卷4期412-4页

1232. Current evidence and future directions for targeting HIV entry: therapeutic and prophylactic strategies.

作者: M P D'Souza.;J S Cairns.;S F Plaeger.
来源: JAMA. 2000年284卷2期215-22页
Great strides have been made in developing potent antiretroviral regimens that block human immunodeficiency virus (HIV) transcription and assembly. Despite these therapeutic advances, problems of drug resistance, latent viral reservoirs, and drug-induced toxic effects that compromise effective viral control point to the need for new classes of anti-HIV drugs with different modes of action. One promising approach involves blocking HIV entry into human cells, a complex process that involves multiple protein interactions. The process of HIV entry begins with binding of the viral envelope glycoprotein to both the CD4 receptor and one of several chemokine receptors and ends with fusion of viral and cell membranes. Conceptually, there are 3 steps in the HIV entry process that could serve as therapeutic targets: binding of the viral envelope glycoprotein with the CD4 receptor, binding of the envelope-CD4 complex to chemokine receptors, and fusion of the viral and cell membranes. Preclinical and clinical assessment of these entry inhibitors is ongoing and will determine if they possess properties required for drug licensure. Moreover, the worldwide epidemic is largely occurring in developing countries that cannot afford these drugs: a prophylactic vaccine is necessary and urgent. New knowledge of the HIV-envelope glycoprotein has also provided insight into possibilities for the design of novel HIV vaccines. JAMA. 2000;284:215-222

1233. Ischemic stroke risk with oral contraceptives: A meta-analysis.

作者: L A Gillum.;S K Mamidipudi.;S C Johnston.
来源: JAMA. 2000年284卷1期72-8页
The relationship between ischemic stroke and oral contraceptive (OC) use has been studied for 40 years, but disagreement about an association persists.

1234. A clinical practice guideline for treating tobacco use and dependence: A US Public Health Service report. The Tobacco Use and Dependence Clinical Practice Guideline Panel, Staff, and Consortium Representatives.

来源: JAMA. 2000年283卷24期3244-54页
To summarize the recently published US Public Health Service report Treating Tobacco Use and Dependence: A Clinical Practice Guideline, which provides recommendations for brief clinical interventions, intensive clinical interventions, and system changes to promote the treatment of tobacco dependence.

1235. The rational clinical examination. Does this patient have carpal tunnel syndrome?

作者: C A D'Arcy.;S McGee.
来源: JAMA. 2000年283卷23期3110-7页
History taking and physical examination maneuvers, including Tinel and Phalen signs, are widely used for the diagnosis of carpal tunnel syndrome (CTS).

1236. Recommendations for the establishment of primary stroke centers. Brain Attack Coalition.

作者: M J Alberts.;G Hademenos.;R E Latchaw.;A Jagoda.;J R Marler.;M R Mayberg.;R D Starke.;H W Todd.;K M Viste.;M Girgus.;T Shephard.;M Emr.;P Shwayder.;M D Walker.
来源: JAMA. 2000年283卷23期3102-9页
To develop recommendations for the establishment and operation of primary stroke centers as an approach to improve the medical care of patients with stroke.

1237. Mortality and prehospital thrombolysis for acute myocardial infarction: A meta-analysis.

作者: L J Morrison.;P R Verbeek.;A C McDonald.;B V Sawadsky.;D J Cook.
来源: JAMA. 2000年283卷20期2686-92页
Early administration of thrombolysis for acute myocardial infarction (AMI) may improve survival if safely and appropriately delivered. No systematic reviews that have comprehensively examined this topic exist in the literature.

1238. Pulmonary artery catheterization and clinical outcomes: National Heart, Lung, and Blood Institute and Food and Drug Administration Workshop Report. Consensus Statement.

作者: G R Bernard.;G Sopko.;F Cerra.;R Demling.;H Edmunds.;S Kaplan.;L Kessler.;H Masur.;P Parsons.;D Shure.;C Webb.;H Weidemann.;G Weinmann.;D Williams.
来源: JAMA. 2000年283卷19期2568-72页
The efficacy and safety of the pulmonary artery catheter are under scrutiny because of its association with increased morbidity and mortality in observational studies. In response, the National Heart, Lung, and Blood Institute (NHLBI) and the US Food and Drug Administration (FDA) conducted the Pulmonary Artery Catheterization and Clinical Outcomes workshop in Alexandria, Va, on August 25 and 26, 1997, to develop recommendations regarding actions to improve pulmonary artery catheter utility and safety.

1239. Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel.

作者: M S Hirsch.;F Brun-Vézinet.;R T D'Aquila.;S M Hammer.;V A Johnson.;D R Kuritzkes.;C Loveday.;J W Mellors.;B Clotet.;B Conway.;L M Demeter.;S Vella.;D M Jacobsen.;D D Richman.
来源: JAMA. 2000年283卷18期2417-26页
Assays for drug resistance testing in human immunodeficiency virus type 1 (HIV-1) infection are now available and clinical studies suggest that viral drug resistance is correlated with poor virologic response to new therapy. The International AIDS Society-USA sought to update prior recommendations to provide guidance for clinicians regarding indications for HIV-1 resistance testing.

1240. Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.

作者: T V Inglesby.;D T Dennis.;D A Henderson.;J G Bartlett.;M S Ascher.;E Eitzen.;A D Fine.;A M Friedlander.;J Hauer.;J F Koerner.;M Layton.;J McDade.;M T Osterholm.;T O'Toole.;G Parker.;T M Perl.;P K Russell.;M Schoch-Spana.;K Tonat.
来源: JAMA. 2000年283卷17期2281-90页
The Working Group on Civilian Biodefense has developed consensus-based recommendations for measures to be taken by medical and public health professionals following the use of plague as a biological weapon against a civilian population.
共有 2156 条符合本次的查询结果, 用时 4.5521606 秒